Xenetic Biosciences, Inc.XBIONASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank62
3Y CAGR-40.1%
5Y CAGR-60.0%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-40.1%/yr
vs +51.1%/yr prior
5Y CAGR
-60.0%/yr
Recent acceleration
Acceleration
-91.2pp
Decelerating
Percentile
P62
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 2.46 | +18.5% |
| 2023 | 2.08 | -12.6% |
| 2022 | 2.38 | -79.2% |
| 2021 | 11.42 | -61.7% |
| 2020 | 29.84 | -87.6% |
| 2019 | 240.69 | - |
| 2018 | 0.00 | -100.0% |
| 2017 | 2.19 | -79.4% |
| 2016 | 10.65 | - |
| 2015 | 0.00 | - |